Fact CheckerSign in

NCT01759186Active, not recruiting

Airway Redox and Gender Determinants in Severe Asthma

Severe Asthma Research Program

Source: ClinicalTrials.gov · Last updated 7 Jul 2026

Brief summary (registry, in English)

The investigators will study the biologic and chemical differences that cause the greater incidence, and severity of asthma in women as compared to men. Severe asthma affects boys more than girls, while severe asthma in adults is predominantly a disease of women. The investigators aim to identify the processes that occur in the body that are behind the onset of severe asthma in young women during the teenage years, and the resolution of severe asthma in boys. To further evaluate gender influences on asthma, asthmatic women at different stages of their menstrual cycle (period) will be also studied. The investigators aim to use biomarkers to develop testing procedures that will identify different types or characteristics of asthma in men and women; and to follow patients over time to uncover relevant clinical outcomes of biomarkers. The investigators anticipate that they will 1) develop clinically relevant tests to identify unique types or characteristics of asthma and severe asthma; 2) determine outcomes over time of biochemically-defined types of asthma; and 3) identify the reasons for why adult women are affected more than men with severe asthma.

Status (registry)
Active, not recruiting
Study type
Observational
Enrollment
300 (estimated)
First submitted
16 Nov 2012
Start date
Dec 2012
Primary completion date
Aug 2027
Lead sponsor
The Cleveland Clinic
Diseases
Asthma
NCT number
NCT01759186

What you commit to

  • Study type: Observational
  • Planned participants: 300
  • From Dec 2012 to the primary completion date, Aug 2027
  • 4 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Other chronic pulmonary disorders associated with asthma-like symptoms, including (but not limited to) cystic fibrosis, chronic obstructive pulmonary disease, chronic bronchitis, vocal cord dysfunction (that is the sole cause of respiratory symptoms and at the PI's discretion)
  • History of premature birth before 35 weeks gestation

Age

  • Smoking history \> 10 pack years if ≥30 years of age, or smoking history \> 5 pack years if \<30 years of age (Note: if a subject has a smoking history, no smoking within the past year),

Other

  • Pregnancy during the characterization phase
  • Current smoking
  • Severe scoliosis or chest wall deformities
  • Unwillingness to receive an intramuscular triamcinolone acetonide injection.

Who the study is looking for

  • Subjects with asthma
  • children age 6-17 years old (25% enrollment)
  • adults 18 years and older (75% enrollment)

Age in the registry: 6 years to 80 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (4)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Virginia
Coordinator of this site? Confirm its status
CharlottesvilleUnited StatesUnknown status
Rainbow Babies and Children's Hospital
Coordinator of this site? Confirm its status
ClevelandUnited StatesUnknown status
Cleveland Clinic
Coordinator of this site? Confirm its status
ClevelandUnited StatesUnknown status
Virginia Commonwealth University
Coordinator of this site? Confirm its status
RichmondUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.